Checkpoint immunotherapy rejects primary tumors without cDC1 cells or lasting immune memory
A new study has revealed that immune checkpoint blockade can drive the first wave of tumor rejection even when a ...
A new study has revealed that immune checkpoint blockade can drive the first wave of tumor rejection even when a ...
In a breakthrough that could revolutionize cancer immunotherapy, a research team at Baylor College of Medicine, led by the late ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine